• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vaxil Bio Ltd

+ Add to Watchlist

VAXL:IT

118.30 ILs 11.40 10.66%

As of 10:24:22 ET on 09/18/2014.

Snapshot for Vaxil Bio Ltd (VAXL)

Open: 106.90 Day's Range: 108.00 - 127.00 Volume: 120,824
Previous Close: 106.90 52wk Range: 63.60 - 239.00 1-Yr Rtn: -6.48%

Stock Chart for VAXL

No chart data available.
  • VAXL:IT 115.10
  • 1D
  • 1M
  • 1Y
106.90
Interactive VAXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VAXL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.6364
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 17.00
Shares Outstanding (M) 14.37
30 Day Average Volume 52,697
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VAXL

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for VAXL

Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.

Lior CarmonFounder/CEO/Head:ResearchJulian LevyPresident/CFO
Riva KovjazinDirector:ResearchOfira MoranClinical Trials Monitoring
More Company Profile & Key Executives for VAXL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil